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Background
Sexually transmitted diseases are predominantly
acquired via mucosal membranes of the rectal or genital
tract during sexual intercourse. This major port of virus
entry is naturally defended by the humoral immune
response, with immunoglobulin A (IgA) as the primary
antibody class to elicit mucosal immunity. Dimeric IgA
(dIgA) reaches the luminal side of mucosal tissues by
transcytosis through epithelial cells lining the mucosa.
In a first step, dIgAs specifically bind to the basolaterally
expressed polymeric immunoglobulin receptor (pIgR) on
epithelial cells. For release of IgAs on the luminal side
the extracellular portion, termed secretory component
(SC), remains attached to the antibody to form secretory
IgA (sIgA) [1,2].
One example of a sexually transmitted disease is the
human immunodeficiency virus (HIV) which annually
infects several million individuals on a global scale and
potentially leads to the acquired immunodeficiency syn-
drome (AIDS). Although current therapies can reduce
disease progression in infected individuals, no cure is
yet available or within reach in near future. As a conse-
quence increased attention is now being paid to develop
drugs that could prevent virus acquisition.
3D6 and 4B3 are two monoclonal antibodies (mAb)
which have originally been isolated as IgG1 isotype from
seroconverted HIV-1 patients and bind to the principal
immunodominant domain of gp41. In the course of this
project both mAbs were isotype switched to IgA1.
Recombinant CHO cell lines were established for the
production of 3D6 and 4B3 as dimeric as well as secre-
tory IgA. While dIgA were expressed by a single cell
line, sIgA are produced by a biochemical association of
dIgA with SC. Both dIgA and sIgA variants were charac-
terized and the contribution of the heavily glycosylated
SC on IgA stability will be investigated.
Antibody expression
MAbs 3D6 and 4B3 (IgG1) were developed at the Insti-
tute of Applied Microbiology [3,4]. Isotype switching
was performed by substitution of the original heavy
chain constant region with that for IgA1 (GenBank
Accession Number 184743). For their recombinant
expression as dIgA three plasmids were generated con-
taining the coding region of either heavy chain, light
chain or joining (J) chain. The latter one should increase
dimerization of IgA monomers. Recombinant CHO
clones were selected whereas high producers were iso-
lated by applying the dihydrofolate reductase (dhfr)
system.
Assembly of 3D6 and 4B3 as sIgA is intended by an in
vitro biochemical association of dimeric IgA with human
secretory component (hSC). Thus, CHO cell lines which
solely express hSC were established by co-transfection
of two plasmids containing the coding region for hSC
and dhfr, respectiviely.
Cultivation temperature greatly influences
productivity
Mammalian cells are commonly cultivated at 37°C. In
order to investigate the effect on mAb secretion, clones
expressing 3D6-dIgA and 4B3-dIgA were propagated at
sub-physiological temperatures. It was observed that
temperature markedly impacts final IgA quantities in
culture supernatants. Product titers of clones expressing
3D6-dIgA were almost 3-fold increased when incubated
at 33 °C as compared to 37 °C. Furthermore, cultivation
of 4B3-dIgA-expressing clones at 33 °C, rather than at
37 °C, resulted in end titers which were approximately
13-fold increased.
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Purification of recombinant dIgA
The two established mAb-expressing cell lines secrete
dIgA at different quantities: The best clone producing
3D6-dIgA achieved a mean specific productivity of 59.1
±14 pg/cell*day (pcd). Conversely, the highest 4B3-dIgA
secreting clone reaches a mean specific productivity of
0.6±0.4 pcd. Hence, an increased amount of host cell
proteins is present in cell culture supernatants of 4B3-
dIgA as compared to 3D6-dIgA. Therefore, we elabo-
rated a purification protocol which allows the recovery
of both dimeric IgAs at a greatly enhanced purity. The
purification procedure is shown in table 1.
Formation of secretory IgA
Secretory IgA can be assembled in vitro due to the nat-
ural affinity of dimeric IgA for secretory component and
vice versa (5). Initially, supernatants from recombinant
cell lines expressing hSC, 3D6-dIgA or 4B3-dIgA were
buffer exchanged against PBS. Subsequently, sIgA for-
mation was performed by incubation of hSC with dIgA
at 25°C for 3 hours at different molar ratios. However,
applying a molar ratio of 1:1 is commonly described as
optimal [5]. The association of 3D6-dIgA or 4B3-dIgA
with hSC was successfully verified by SDS-PAGE follow-
ing Western blotting (data not shown). Conjugation of
the immunoblot was performed with a mouse anti-
human secretory component antiserum (Sigma) and
detected via an anti-mouse IgG1 antiserum (Sigma).
Conclusions
The anti-HIV-1 mAbs 3D6 and 4B3 were isotype
switched and could successfully be expressed as dIgA in
stably transfected CHO cells. Furthermore, continuous
product secretion was obtained for at least 20 passages
in spinner flasks.
Cultivation of the recombinant cell lines at different
temperatures revealed that their product expression can
markedly be influenced: 3D6-dIgA expression was nearly
triplicated by shifting the temperature from 37 °C to 33
°C. Applying the same conditions, 4B3-dIgA product
secretion was nearly 13-fold increased.
A purification protocol was developed which allows
the recovery of the dIgAs 3D6 and 4B3 in highly pure
fractions. Furthermore, the elaborated scheme enables
the isolation of dimeric 3D6 from its various high mole-
cular weight isotypes.
Secretory IgA of both 3D6 and 4B3 can successfully
be produced by mixing dimeric IgA with human secre-
tory component.
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Table 1 Purification scheme developed for isolation of 3D6 and 4B3 dIgA.
STEP EQUIPMENT PROCEDURE RECOVERY
3D6
dIgA
4B3
dIgA
Ultra/Diafiltration Kvick Start UDF Cassette,
Millipore, 30 kD
Harvested cell culture supernatant containing dIgA is concentrated and buffer
exchanged against PBS, pH 7.4
>95
%
>95
%
Lectin Affinity
Chromatography
Immobilized Jacalin,
Thermo Scientific
UDF retentate is immobilized onto a lectin affinity resin. After a washing step,
bound product is eluted by applying 1.5 M D-galactose in PBS, pH 7.4
98.7
%
106.1
%
Ultra/Diafiltration Kvick Start UDF Cassette,
Millipore, 30 kD
The eluate is buffer exchanged against 20 mM Tris, 10 mM NaCl, pH 8.5 >95
%
>95
%
Anion Exchange
Chromatography
DEAE Sepharose FF, GE
Healthcare
The retentate is applied onto the anion exchanger. Post washing with 100mM
NaCl product is eluted from the resin using 20 mM Tris, 200 mM NaCl, pH 8.5
88.4
%
86.7
%
Hydrophobic
Interaction
Chromatography
Phenyl-Sepharose 6FF
low sub, GE Healthcare
(NH4)2SO4 is added to 0.75 M for 4B3-dIgA or 1.25 M for 3D6-dIgA to precipitate
host cell proteins but not mAb itself. After a washing step 3D6-dIgA is eluted
with 0.4 M (NH4)2SO4, which allows to isolate dimeric IgA from other IgA
isoforms. 4B3-dIgA desorbs at 0 M (NH4)2SO4
44.1
%
59.1
%
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